Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial design.
Reig M, Rimola J, Torres F, Darnell A, Rodriguez-Lope C, Forner A, Llarch N, Ríos J, Ayuso C, Bruix J.
Hepatology.   2013
Dec;
58(6):2023-31.